Acute respiratory distress syndrome development in patients with coronavirus disease 2019
(COVID-19) pneumonia is associated with a high mortality rate and is the main cause of …

Introduction Coronavirus disease 2019 (COVID-19) pneumonia is associated to systemic
hyper-inflammation and abnormal coagulation profile. D-dimer elevation is particularly …

Recent studies suggest that thrombotic complications are a common phenomenon in the
novel SARS-CoV-2 infection. The main objective of our study is to assess cumulative …

Abstract Background Coronavirus disease 2019 (COVID-19) is characterised by dyspnoea
and abnormal coagulation parameters, including raised D-dimer. Data suggests a high …

Purpose To investigate, in a meta-analysis, the frequency of pulmonary embolism (PE) in
patients with COVID-19 and whether D-dimer assessment may be useful to select patients …

Background Pulmonary embolism (PE) has been described in coronavirus disease 2019
(COVID-19) critically ill patients, but the evidence from more heterogeneous cohorts is …

Objectives To investigate whether COVID-19 patients with pulmonary embolism had higher
mortality and assess the utility of d-dimer in predicting acute pulmonary embolism. Patients …

Background Coronavirus disease 2019 (COVID-19) may predispose to venous
thromboembolism. We determined factors independently associated with computed …

Background Pulmonary embolism (PE) commonly complicates SARS-CoV-2 infection, but
incidence and mortality reported in single-center studies, along with risk factors, vary …

Purpose COVID-19 raises D-dimer (DD) levels even in the absence of pulmonary embolism
(PE), resulting in an increase in computed tomography pulmonary angiogram (CTPA) …